Follow
Pieter Jelle Visser
Pieter Jelle Visser
Maastricht University and VU University Medical Centre
Verified email at vumc.nl
Title
Cited by
Cited by
Year
Mild cognitive impairment–beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
B Winblad, K Palmer, M Kivipelto, V Jelic, L Fratiglioni, LO Wahlund, ...
Journal of internal medicine 256 (3), 240-246, 2004
50472004
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
B Dubois, HH Feldman, C Jacova, ST DeKosky, P Barberger-Gateau, ...
The Lancet Neurology 6 (8), 734-746, 2007
50112007
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ...
The Lancet Neurology 13 (6), 614-629, 2014
28622014
Revising the definition of Alzheimer's disease: a new lexicon
B Dubois, HH Feldman, C Jacova, JL Cummings, ST DeKosky, ...
The Lancet Neurology 9 (11), 1118-1127, 2010
22092010
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ...
Alzheimer's & dementia 10 (6), 844-852, 2014
17202014
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment
N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ...
Jama 302 (4), 385-393, 2009
12852009
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
11522015
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium …
F Portet, PJ Ousset, PJ Visser, GB Frisoni, F Nobili, P Scheltens, B Vellas, ...
Journal of Neurology, Neurosurgery & Psychiatry 77 (6), 714-718, 2006
7712006
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA …
PJ Visser, F Verhey, DL Knol, P Scheltens, LO Wahlund, Y Freund-Levi, ...
The Lancet Neurology 8 (7), 619-627, 2009
6562009
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease
GB Karas, P Scheltens, SARB Rombouts, PJ Visser, RA van Schijndel, ...
Neuroimage 23 (2), 708-716, 2004
6552004
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
SJB Vos, C Xiong, PJ Visser, MS Jasielec, J Hassenstab, EA Grant, ...
The Lancet Neurology 12 (10), 957-965, 2013
5462013
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis
R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ...
Jama 313 (19), 1939-1950, 2015
4992015
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment
PJ Visser, FRJ Verhey, PAM Hofman, P Scheltens, J Jolles
Journal of Neurology, Neurosurgery & Psychiatry 72 (4), 491-497, 2002
4312002
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ...
The Lancet Neurology 16 (8), 661-676, 2017
4232017
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
ESC Korf, LO Wahlund, PJ Visser, P Scheltens
Neurology 63 (1), 94-100, 2004
4222004
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment
PJ Visser, P Scheltens, FRJ Verhey, B Schmand, LJ Launer, J Jolles, ...
Journal of neurology 246 (6), 477-485, 1999
3881999
Optimizing patient care and research: the Amsterdam Dementia Cohort
WM van der Flier, YAL Pijnenburg, N Prins, AW Lemstra, FH Bouwman, ...
Journal of Alzheimer's disease 41 (1), 313-327, 2014
3262014
Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage
SJB Vos, F Verhey, L Frölich, J Kornhuber, J Wiltfang, W Maier, O Peters, ...
Brain 138 (5), 1327-1338, 2015
3032015
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
2982019
Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update
M Del Campo, B Mollenhauer, A Bertolotto, S Engelborghs, H Hampel, ...
Biomarkers in medicine 6 (4), 419-430, 2012
2922012
The system can't perform the operation now. Try again later.
Articles 1–20